Advanced search
Publication Cover
Toxicology Communications Volume 8, 2024 - Issue 1
Submit an article Journal homepage
100
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Non-adherence with long-term oral vitamin K1 therapy in acute long-acting anticoagulant rodenticides poisoning: a call for action

Israel Rubinsteina Department of Medicine, University of Illinois College of Medicine in Chicago, Chicago, IL, USA;b Medical Service, Jesse Brown VA Medical Center, Chicago, IL, USA;c Research and Development Services, Jesse Brown VA Medical Center, Chicago, IL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3628-0601View further author information
ORCID Icon,
Malvika Kaula Department of Medicine, University of Illinois College of Medicine in Chicago, Chicago, IL, USAView further author information
&
Douglas L. Feinsteinc Research and Development Services, Jesse Brown VA Medical Center, Chicago, IL, USA;d Department of Anesthesiology, University of Illinois College of Medicine in Chicago, Chicago, IL, USAView further author information
Article: 2314301 | Received 01 Jan 2024, Accepted 25 Jan 2024, Published online: 12 Apr 2024

References

  • Lurie Y, Nadir Y, Hoffman R, et al. An outbreak of severe coagulopathy in Northern Israel among users of illicit synthetic cannabinoids adulterated with brodifacoum. Clin Toxicol (Phila). 2023;61(6):1–2. doi: 10.1080/15563650.2023.2215402.
  • Kelkar AH, Smith NA, Martial A, et al. An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois. N Engl J Med. 2018;379(13):1216–1223. doi: 10.1056/NEJMoa1807652.
  • Wright E, Hafner JW, Podolej G, et al. Severe vitamin K-dependent coagulopathy from rodenticide-contaminated synthetic cannabinoids: emergency department presentations. West J Emerg Med. 2021;22(4):1014–1019. doi: 10.5811/westjem.2021.2.46317.
  • Coble N, Mulay P, Funk A, et al. Notes from the field: coagulopathy associated with brodifacoum poisoning – Florida, December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(40):1288–1290. doi: 10.15585/mmwr.mm7140a5.
  • Feinstein DL, Nosal DG, Ramanathan S, et al. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids. Clin Toxicol (Phila). 2020;58(7):716–724. doi: 10.1080/15563650.2019.1687903.
  • Yip L, Stanton NV, Middleberg RA. Vitamin K1 treatment duration in patients with brodifacoum poisoning. N Engl J Med. 2020;382(18):1764–1765. doi: 10.1056/NEJMc1916199.
  • Nosal DG, van Breemen RB, Haffner JW, et al. Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy. Toxicol Commun. 2021;5(1):69–72. doi: 10.1080/24734306.2021.1887637.
  • van Breemen RB, Hafner JW, Nosal DG, et al. Unmet clinical laboratory need in patients hospitalized for acute poisoning from long-acting anticoagulant rodenticides. Toxicol Commun. 2021;5(1):93–96. doi: 10.1080/24734306.2021.1925444.
  • Tole M, LaBedz S, Feinstein DL, et al. Adherence to long-term follow-up of patients with life-threatening, inhaled synthetic cannabinoids-associated coagulopathy in Chicago. Lung. 2019;197(3):349–352. doi: 10.1007/s00408-019-00227-2.
  • Lindeblad M, Lyubimov A, van Breemen R, et al. The bile sequestrant cholestyramine increases survival in a rabbit model of brodifacoum poisoning. Toxicol Sci. 2018;165(2):389–395. doi: 10.1093/toxsci/kfy147.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.